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Abstract
Background: To report a case of branch retinal vein occlusion in a young adult with bipolar mood disorder
treated with quetiapine fumarate.
Case Presentation: A 29 years old gentleman who was taking quetiapine fumarate for 3 years for bipolar mood
disorder, presented with sudden vision loss. He was found to have a superior temporal branch retinal vein
occlusion associated with hypercholesterolemia.
Conclusion: Atypical antipsychotic drugs have metabolic side effects which require regular monitoring and
prompt treatment.
Background
Retinal vein occlusions (RVOs) frequently occur in the
elderly in association with atherosclerosis. Hypertension is
the commonest cause of RVOs in such population. In
young adults, RVOs are associated with vasculitis and coa-
gulopathies. Extensive work-up is required as both vasculi-
tis and coagulopathies can lead to severe systemic
morbidity and mortality. We describe a case of branch ret-
inal vein occlusion in a young adult who has been taking
quetiapine fumarate for 3 years.
Case Presentation
A 29 years old gentleman was referred from the emer-
gency department with the complaint of sudden painless
vision loss of his left eye for the past 1 week. Since onset,
he experienced progressive generalized blurring of the
central vision. There was neither photopsia nor floaters.
Systemic review was not significant. He has no symptoms
and signs of systemic vasculitis such as rashes, joint pains
or mucosal surface ulcers. He was diagnosed of bipolar
mood disorder in 2008, and was treated with oral quetia-
pine fumarate 100 mg daily. His bipolar mood disorder
responded well to quetiapine fumarate without any side
effects. Sexual history was not significant and he has no
history of substance abuse or smoking. There was no
family history of vascular events as well.
He was a medium built individual with a body mass
index of 24.83 kg/m
2 (height 165.5 cm, body weight
68 kg). His body weight prior to quetiapine treatment was
62 kg. Blood pressure was 122/74 mmHg with a regular
pulse rate of 80 beats per minute. The visual acuity of his
left eye was 0.33, with near visual acuity of N24 at 33 cm.
The right eye had visual acuity of 1.0 and near vision of
N6 at 33 cm. Confrontation test revealed a left central sco-
toma. Relative afferent pupillary defect was absent. Ante-
rior segment examination for both eyes was normal. The
intraocular pressure was 16 mmHg bilaterally.
Posterior segment examination of the left eye revealed
flame-shaped retinal haemorrhages along an arcuate
course, corresponding to the supero-temporal retinal
nerve fibre layer. Macular oedema involved the fovea and
was associated with partial macular star due to hard exu-
dates deposition. Intraretinal pigmentary spots with adja-
cent typical red blot hemorrhages believed to be
resolving blot hemorrhages were seen. The patient has
never had any laser treatment before. The supero-tem-
poral retinal vein was dilated and tortuous along its
entire course (Figure 1). The arterio-venous ratio was 2:3
infero-temporally but was 1:3 supero-temporally. There
were increased arteriole reflexes with arterovenous nick-
ing which was confined only to the supero-temporal ret-
inal artery of the left eye. The optic disc was pink with
well-defined margin and cup-disc ratio of 0.5. There was
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disc diameter temporal to the fovea. The retinal haemor-
rhages were oriented along the distal infero-temporal ret-
inal nerve fiber layer but did not begin at the retinal
artery-vein intersection. The infero-temporal retinal vein
was neither dilated nor tortuous (Figure 2). There were
no cotton wool spots, the vitreous was clear, and there
was no evidence of retinal periarteritis or periphlebitis.
Posterior segment findings of the right eye were not sig-
nificant (Figure 3).
Optical coherence tomography (Heidelberg Spectralis
®
Tracking Laser Tomography) revealed the thickness of
the superior half of the fovea was increased, with central
serous neurosensory retinal detachment (Figure 4). Full
blood count, renal profile, liver function test and thyroid
function test were all normal. Erythrocyte sedimentation
Figure 1 Fundus photograph of the left eye; macula centered.
Figure 2 Fundus photograph of the left eye; temporal retinal field.
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Page 2 of 6rate was 3 mm/hour, C-reactive protein was 0.05 mg/dl.
Connective tissue screening test (antinuclear antibodies,
anti double-stranded DNA antibodies, rheumatoid fac-
tor), Venereal Disease Research Laboratory test and
enzyme-linked immunosorbent assay for human immu-
nodeficiency virus were all negative. Fasting blood sugar
was 4.7 mmol/L. However, annual lipid profile showed
progressive derangement. The total cholesterol, triglycer-
ide and LDL-cholesterol levels showed an increasing
trend. While the HDL-choleterol levels were progressing
in the opposite direction (Table 1). Chest radiography
was normal.
The patient was diagnosed to have left major superior
temporal branch retinal vein occlusion complicated by
macula oedema. The cause of the RVO was attributed to
dyslipidaemia secondary to quetiapine fumarate. The con-
dition was conveyed to his psychiatrist, and he was subse-
quently referred to the internist for the management of his
dyslipidaemia. The patient was treated with oral lovastatin
20 mg daily. His lipid profile normalized after 2 months
but the final visual acuity remained 0.33 and near visual
acuity N24 at 33 cm due to the presence of hard exudates
at the fovea.
Discussion
Retinal vascular diseases are ocular manifestations of
underlying systemic vascular disorders. The eyes are the
only place in the body which allow direct visualization
of the blood vessels. Therefore fundus examination
offers a valuable opportunity for the early detection of
occult systemic vascular disorders. Cugati et al in his
analysis of 2 population-based cohorts (Beaver Dam Eye
Study and Blue Mountains Eye Study) found out that
participants aged less than 70 years old with retinal vein
occlusion (RVO) at baseline were associated with higher
cardiovascular mortality [1].
Being a part of the entity, RVO is the second most
common retinal vascular disease after diabetic retinopa-
thy. The true prevalence of retinal vein occlusive disorder
is difficult to establish as many of them are asymptomatic
and only diagnosed incidentally, unless it is complicated
and visual disturbances manifest. Peripheral branch
RVOs are asymptomatic. Symptomatic RVOs are due to
macular involvement in which patients present loss of
central vision. Macula oedema is the major cause of cen-
tral visual loss in RVOs [2]. Nonetheless, data from longi-
tudinal population based study has lead the Blue
Mountain Eye Study to conclude the 10-year cumulative
incidence of RVO to be at 1.6%, and it was greatly asso-
ciated with increasing age especially those above 70 years
old [3].
Although the vast majority of RVO are found in the
middle aged and elderly population, it can affect young
adults too. In a retrospective review of 60 cases, Lam et
al found that only 1.7% of all branch retinal vein occlu-
sions (BRVO) occurred in individual aged 49 or younger.
Systemic hypertension, hyperlipidemia and increased
body mass index are important risk factors for BRVO in
this group of patients [4]. However, Lam et al did not test
their young subjects for hypercoagulability or collagen
vascular disease, and therefore they cannot comment on
the need for more extensive work-up for such patients.
Figure 3 Fundus photograph of the right eye.
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tics that is currently in use for the treatment of many
psychiatric disorders. Unliket h eo l d e rp h e n o t h i a z i n e -
type drugs, these atypical antipsychotics block both the
dopamine-2 receptor and the serotonin 5-HT2A recep-
tor; hence making them a versatile group of drug to treat
a wide variety of psychiatric disorders [5]. Another
advantage of these second generation antipsychotics is
Figure 4 Optical coherence tomography of the left eye.








Total Cholestrol (mmol/L) 4.28 4.46 5.09 <5.7
Triglycerides (mmol/L) 1.11 1.63 1.99 <1.4
HDL (mmol/L) 1.27 0.87 0.76 >1.2
LDL (mmol/L) 2.51 2.84 3.43 <3.8
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tardive dyskinesia. The safety of these new atypical anti-
psychotics compared to the older phenothiazines is
uncertain as they can cause serious adverse drug
reactions.
Atypical antipsychotic agents increase the risk of glucose
intolerance, dyslipidaemia and weight gain [6]. Quetiapine
fumarate has been associated with high triglycerides in 23
percent and high cholesterol in 16 percent of patients tak-
ing it [7]. Olfson et al found that treatment with quetia-
pine was associated with increased risk of incidence of
hyperlipidaemia (odds ratio:1.52, 95% CI: 1.40-1..65) [8].
Our patient had a normal baseline laboratory results, but
went on to develop dyslipidaemia following 2 years of que-
tiapine treatment. Even though there is a link between
dyslipidaemia and BRVO, the evidence in this case is not
very strong since the patient’s dyslipidaemia was not
severe. Nevertheless, we must be vigilant and intervene at
the first sign of dyslipidaemia before the patient develops
central retinal vein occlusion, stroke or any cardiovascular
event. In 2004, the American Diabetes Association, the
American Psychiatric Association, the American Associa-
tion of Clinical Endocrinologists, and the North American
Association for the Study of Obesity consensus statement
recommended that fasting plasma glucose, lipid levels, and
blood pressure should also be assessed 3 months after
initiation of antipsychotic medications. In those with a
normal lipid profile, repeat testing should be performed at
5-year intervals or more frequently if clinically indicated
[9].
The subtle worsening dyslipidaemia in this patient
resulted in a thrombogenic environment that led to the
development of BRVO. The localized increased arteriole
reflexes with arteriovenous nicking found only along the
right supero-temporal retinal artery were believed to be
the sequelae of BRVO rather than the cause of it. This is
due to hypoxia which induced localized microglial cells
proliferation along the right supero-temporal retinal artery
[10].
There was a smaller zone of flame shaped haemorrhages
at the inferior temporal arcade. Features characteristic for
a branch retinal vein occlusion were absent in this area.
The presence of a peripheral branch retinal vein occlusion
at this area is very difficult to prove without fluorescein
angiography. We did not perform fluorescein angiography
at the time of diagnosis because we felt that the risk out-
weighed the benefit, since the confirmation of the second
smaller inferior temporal BRVO will not alter our manage-
ment. To the best of the authors’ knowledge, this is the
first case of BRVO associated with quetiapine. This case
report emphasize the importance of regular monitoring
and prompt intervention of any metabolic derangement in
order to avert severe morbidity and mortality.
Conclusions
RVOs in young adults require careful systemic evaluation
for the presence of cardiovascular risk factors as well as
to exclude hypercoagulabilities or collagen vascular dis-
eases. The usage of antipsychotics medications require
regular monitoring and prompt intervention for any
metabolic side effects and adverse drug reactions.
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